JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-8-12
N.N. Omelchuk
The Significance of Corticosteroid Binding to Plasma Proteins in the Mechanism of the Effect
of the Radioprotector Rs-11 on the Function of the Adrenal Cortex in Acute Radiation Sickness
Russian University of Friendship of Peoples Patrice Lumumba, Moscow, Russia
Contact person: N.N. Omelchuk, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To study the role of binding of corticosteroids to blood plasma proteins in the mechanism of influence of the radioprotector RS-11 on the function of the adrenal cortex in irradiated animals.
Material and methods: The experiments were carried out on 30 male chinchilla rabbits weighing 2.5–3.0 kg. The first series of experiments is aimed at studying the reaction of the adrenal cortex and the processes of protein-steroid interaction after the administration of PC-11 to intact animals; in the second series – the same indicators in animals irradiated during the prophylactic administration of RS-11. The total content of 11-hydroxycorticosteroids (11-OKS) in blood plasma was determined by the fluorometric method of Guillemin et al in the author’s modification. The amount of free corticosteroids was determined by the difference in their content in whole plasma and in its protein fraction after separation on Sephadex G-25. Binding capacity of corticosteroid binding globulin (CSBG) was determined by gel filtration De Moor at al. in the author’s modification. Statistical analysis of the study results was carried out using the Student–Fisher method.
Results: In the group of intact rabbits under conditions of administration of PC-11, the reaction of the adrenal cortex after 2.5–3 hours was significantly higher compared to control animals. The increase in the free fraction of the hormone with the introduction of the radioprotector RS-11 during this period is associated with an increase in the total level of 11-OKS, since the binding ability of CSBG did not change. In the group of irradiated rabbits, 2.5–3 hours after irradiation, the administration of PC-11 also led to a significant increase in the total content of 11-OKS in the blood compared to the initial data. At the height of radiation sickness on the 4th day, RS-11 protected rabbits showed a significantly smaller decrease in the binding capacity of CSBG than control animals, and the total content of 11-OKS was higher than in the control. The level of free hormone on the 4th day was sharply reduced (8 % of the total 11-OKS content versus 41 % in the control). On the 8th day of radiation sickness, free 11-OKS in protected RS-11 and control rabbits was practically absent, however, in protected animals, the binding capacity of CSBG was 2 times higher than in control animals.
Conclusions: The influence of the radioprotector RS-11 leads in the first hours to an increase in the total concentration of 11-OX in the blood plasma and to an increase in the amount of free hormone in intact animals. The binding capacity does not change. Prophylactic administration of RS-11 inhibits, at the height of radiation sickness, the decrease in the binding capacity of CSBG in the blood plasma, and as a result, the increase in the level of free physiologically active hormone at a higher overall level of hormones in the blood. In the mechanism for reducing post-radiation hypercortisolism under conditions of protection with the drug RS-11, the main significance is the lesser degree of disruption of the binding ability of CSBG, and not a change in the overall level of hormones in the blood.
Keywords: acute radiation sickness, protein-steroid interaction, corticosteroids, hypercortisolism, chemical radioprotectors, RS-11
For citation: Omelchuk NN. The Significance of Corticosteroid Binding to Plasma Proteins in the Mechanism of the Effect of the Radioprotector Rs-11 on the Function of the Adrenal Cortex in Acute Radiation Sickness. Medical Radiology and Radiation Safety. 2023;68(6):8–12. (In Russian). DOI:10.33266/1024-6177-2023-68-6-8-12
References
1.Grebenyuk A.N., Strelova O.Yu., Legeza V.I., Stepanova E.N. Osnovy radiobiologii i radiacionnoj mediciny = Fundamentals of radiobiology and radiation medicine: Textbook. SPb.: OOO Izdatelstvo FOLIANT, 2012. 232 p. (In Russ.).
2.Rozhdestvenskij L.M. Past and future of radiobiology of anti-radiation agents at the Institute of Biophysics of the USSR Ministry of Health. FSBI State Scientific Center FMBC named after. A.I. Burnazyan FMBA of Russia. Medicinskaya radiologiya i radiacionnaya bezopasnost = Medical radiology and radiation safety. 2016; 5: 80-89 (In Russ.).
3.Rozhdestvenskij L.M. Problems of developing domestic anti-radiation agents during a crisis period: searching for current development directions. Radiacionnaya biologiya. Radioekologiya = Radiation biology. Radioecology. 2020; 60(3): 290-300 (In Russ.).
4.Khabriev R.U., Mingazova E.N., Sidorov V.V., Gureev S.A., Yusupova M.M. Biocompatible drugs-protectors against radiation exposure: a modern view of the problem. Remedium = Remedium. 2021; 4: 3-8 (In Russ.).
5.Kuruba V., Gollapalli P. Natural radioprotectors and their impact on cancer drug discovery. J. Radiation oncology. 2019; 36(4): 265-275. DOI: 10.3857/roj.2018.00381.
6.Kashiwakura I. Overview of radiation-protective agent research and prospects for the future. Jpn J. Health Physics. 2017; 52 (4): 285-295. DOI: 10.5453/jhps.52.285.
7.Borisova L.Ya. The influence of radioprotective substances on the early radiation reaction of the pituitary-adrenal system. Radiobiologiya = Radiobiology. 1969; 9 (2): 246-248 (In Russ.). PMID: 5343951.
8.Omelchuk N.N. Analysis of the disturbance of corticosteroids with blood plasma proteins in the pathogenesis of acute radiation sickness. Radiaciya i risk = Radiation and risk. 2022; 31(3): 131-138 (In Russ.). DOI: 10.21870/0131-3878-2022-31-3-131-138.
9.Omelchuk N.N. The binding capacity of corticosteroid-binding globulin in blood plasma as a mechanism for increasing the free fraction of the hormone in the pathogenesis of acute radiation sickness. Radiaciya i risk = Radiation and risk. 2022; 31(3): 139-146 (In Russ.). DOI: 10.21870/0131-3878-2022-31-3-139-146.
10. Chernov G.A., Evdakov V.P., Kabanov V.A. Anti-radiation effect of ionic polymers. Selected materials from the Bulletin of Radiation Medicine / Ed. L.A. Ilyin and A.S. Samoilova. T. II. M.: FGBU GNC FMBC im. A.I. Burnazyana FMBA Rossii. Izbrannye materialy «Byulletenya radiacionnoj mediciny» = Institution State Scientific Center FMBC named after. A.I. Burnazyan FMBA of Russia, 2016. P. 607-619 (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The author declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with one participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.